相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors
R. C. S. van Adrichem et al.
ANNALS OF ONCOLOGY (2016)
Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement
Joanne E. Adaway et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2016)
Variation in Cardiac Screening and Management of Carcinoid Heart Disease in the UK and Republic of Ireland
R. Dobson et al.
CLINICAL ONCOLOGY (2015)
The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases
Xu Han et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
A Single Fasting Plasma 5-HIAA Value Correlates With 24-Hour Urinary 5-HIAA Values and Other Biomarkers in Midgut Neuroendocrine Tumors (NETs)
Maria R. Tellez et al.
PANCREAS (2013)
The Association of a Panel of Biomarkers with the Presence and Severity of Carcinoid Heart Disease: A Cross-Sectional Study
Rebecca Dobson et al.
PLOS ONE (2013)
Comparison of 24-h and overnight samples of urinary 5-hydroxyindoleacetic acid in patients with intestinal neuroendocrine tumors
Merete Gedde-Dahl et al.
ENDOCRINE CONNECTIONS (2013)
ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
Massimo Falconi et al.
NEUROENDOCRINOLOGY (2012)
ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
Ulrich-Frank Pape et al.
NEUROENDOCRINOLOGY (2012)
Risk Factors for the Development and Progression of Carcinoid Heart Disease
Sanjeev Bhattacharyya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours
Kjell Oberg
ENDOCRINE-RELATED CANCER (2011)
Chromogranin A-Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Irvin M. Modlin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Chromogranin-A and N-Terminal Pro-Brain Natriuretic Peptide: An Excellent Pair of Biomarkers for Diagnostics in Patients With Neuroendocrine Tumor
Catharina M. Korse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Dermot O'Toole et al.
NEUROENDOCRINOLOGY (2009)
Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors
Rudolf Arnold et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
One hundred years after Carcinoid: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours
Anouk N. A. van der Horst-Schrivers et al.
EUROPEAN JOURNAL OF CANCER (2007)
The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
V. Formica et al.
BRITISH JOURNAL OF CANCER (2007)
Biochemistry of neuroendocrine tumours
Wouter W. de Herder
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
G. B. Turner et al.
GUT (2006)
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors
JM Zuetenhorst et al.
CLINICAL CHEMISTRY (2004)
Carcinoid heart disease -: The role of urinary 5-hydroxyindoleacefic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-β and fibroblast growth factor
JM Zuetenhorst et al.
CANCER (2003)
Mechanisms of disease - The chromogranin-secretogranin family.
L Taupenot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases
P Hellman et al.
WORLD JOURNAL OF SURGERY (2002)
Clinical significance of blood chromogranin A measurement in neuroendocrine tumours
E Seregni et al.
ANNALS OF ONCOLOGY (2001)
分享论文
